Breathe Well Live Well
|
Hayes, Inc. Releases New Report on Bronchial Thermoplasty for Treatment of Asthma
Benzinga Hayes, Inc., a leading provider of unbiased health technology assessments and consulting services, recently released a health technology assessment on bronchial thermoplasty for the treatment of asthma. Since bronchial thermoplasty is a novel approach … |
View full post on asthma – Google News
|
CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data …
PR Newswire (press release) AUSTIN, Texas, Sept. 18, 2013 /PRNewswire/ — The Clinical Data Interchange Standards Consortium (CDISC) and TransCelerate BioPharma Inc. ("TransCelerate"), are pleased to announce that version 1.0 of the Asthma Therapeutic Area (TA) Data Standard … |
View full post on asthma – Google News
|
Plans Work to Improve Asthma Care, Prepare for Wave of New Cases in 2014
Atlantic Information Services, Inc. Facing the prospect of one in five new members with COPD or asthma, Pearson says, “speaks to the ongoing need that commercial and Medicaid plans will have to focus on disease management” and care coordination efforts. Moreover, she notes that health … |
View full post on asthma – Google News
|
Gecko Health Innovations Inc. Features GeckoCap, a Simple Pediatric Asthma …
Virtual-Strategy Magazine (press release) Gecko Health Innovations Inc., a healthcare mobile technology company, announced today that its patent pending new solution for pediatric asthma, GeckoCap™, will be unveiled at the 2013 International CES® in Las Vegas, from January 8-11, in booth … |
View full post on asthma – Google News
|
Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN(R) (Flunisolide …
MarketWatch (press release) AEROSPAN Inhalation Aerosol is an orally inhaled corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age and older. In this double-blind, placebo-controlled study, … |
View full post on asthma – Google News
|
Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 …
DigitalJournal.com (press release) A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's lead peptide mimetic natriuretic peptide receptor A agonist, which is in development for treatment of acute exacerbations of asthma, heart failure and refractory … |
View full post on asthma – Google News
|
Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 …
PR Newswire (press release) A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's lead peptide mimetic natriuretic peptide receptor A agonist, which is in development for treatment of acute exacerbations of asthma, heart failure and refractory … |
View full post on asthma – Google News
|
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
PR Newswire (press release) Palatin has started discussions with a number of potential development and marketing partners for PL-3994 for acute asthma, which would include the proof-of-concept human trial for asthma using a subcutaneously administered formulation and development … Palatin Technologies CEO Discusses F3Q2011 Results – Earnings Call Transcript |
View full post on asthma – Google News
|
Critical Therapeutics Inc. Reports Operating Results (10-K)
GuruFocus.com Asthma is a chronic respiratory disease characterized by the narrowing of the lung airways, making breathing difficult. An asthma attack leaves the victim short of breath as the airways become constricted and inflamed. The National Center for Health … Cornerstone Therapeutics 4Q profit falls on expenses, but results top Wall … |
View full post on asthma – Google News
|
Acton Pharmaceuticals, Inc. Submits NDA Supplement to FDA for AEROSPAN(R …
MarketWatch (press release) AEROSPAN is a hydrofluoroalkane (HFA) propelled inhaled corticosteroid for the treatment of asthma, which will compete in the $7 billion US inhaled steroid … |
View full post on asthma – Google News